As of the latest Form 4 filed Jul 7, 2026.
What Crinetics Pharmaceuticals Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 38 most recent filings for CRNX.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-07 | 2026-07-02 | Vivaldi Coelho Rogerio Director | SSale | −3.00K | $40.00 | $120K | Yes (planned) | Form 4 ↗ |
| 2026-06-22 | 2026-06-18 | Deardorf Caren Director | AAward | +5.92K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-18 | Fust Matthew K Director | AAward | +5.92K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-18 | Nichols Weston Director | AAward | +5.92K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-18 | Vivaldi Coelho Rogerio Director | AAward | +5.92K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-18 | Bedrosian Camille L Director | AAward | +5.92K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-18 | WIERENGA WENDELL Director | AAward | +5.92K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-22 | 2026-06-18 | Okey Stephanie Director | AAward | +5.92K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-18 | 2026-06-17 | Okey Stephanie Director | SSale | −608.00 | $36.22 | $22.0K | Yes (planned) | Form 4 ↗ |
| 2026-06-18 | 2026-06-17 | Okey Stephanie, Director | SSale | −6.29K | $35.62 | $224K | Yes (planned) | Form 4 ↗ |
| 2026-06-02 | 2026-05-29 | Struthers Richard Scott President & CEO | GGift | +111K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-02 | 2026-05-29 | Struthers Richard Scott, President & CEO | GGift | +111K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-02 | 2026-05-29 | Struthers Richard Scott, President & CEO | GGift | −111K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-02 | 2026-05-29 | Struthers Richard Scott, President & CEO | GGift | −111K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-02 | 2026-05-29 | Struthers Richard Scott, President & CEO | GGift | +111K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-02 | 2026-05-29 | Struthers Richard Scott, President & CEO | GGift | +111K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-02 | 2026-05-29 | Struthers Richard Scott, President & CEO | GGift | −111K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-02 | 2026-05-29 | Struthers Richard Scott, President & CEO | GGift | −111K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-02 | 2026-05-29 | Struthers Richard Scott, President & CEO | GGift | +80.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-02 | 2026-05-29 | Struthers Richard Scott, President & CEO | GGift | +222K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-02 | 2026-05-29 | Struthers Richard Scott, President & CEO | GGift | +222K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-02 | 2026-05-29 | Struthers Richard Scott, President & CEO | GGift | −80.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-02 | 2026-05-29 | Struthers Richard Scott, President & CEO | GGift | −222K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-02 | 2026-05-29 | Struthers Richard Scott, President & CEO | GGift | −222K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-10 | 2026-04-08 | Knight Jeff E. Chief Dev. & Operating Officer | SSale | −85.2K | $40.10 | $3.42M | Yes (planned) | Form 4 ↗ |
| 2026-04-10 | 2026-04-08 | Knight Jeff E., Chief Dev. & Operating Officer | MExercise | +19.3K | $19.64 | $380K | Yes (planned) | Form 4 ↗ |
| 2026-04-10 | 2026-04-08 | Knight Jeff E., Chief Dev. & Operating Officer | MExercise | +9.62K | $20.02 | $193K | Yes (planned) | Form 4 ↗ |
| 2026-04-10 | 2026-04-08 | Knight Jeff E., Chief Dev. & Operating Officer | MExercise | +49.5K | $23.98 | $1.19M | Yes (planned) | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | Knight Jeff E. Chief Operating Officer | SSale | −3.96K | $37.77 | $150K | Yes (planned) | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | Knight Jeff E., Chief Operating Officer | SSale | −5.95K | $37.11 | $221K | Yes (planned) | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | Betz Stephen F. Chief Scientific Officer | SSale | −4.24K | $37.77 | $160K | Yes (planned) | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | Betz Stephen F., Chief Scientific Officer | SSale | −6.37K | $37.11 | $236K | Yes (planned) | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | Struthers Richard Scott President & CEO | SSale | −8.79K | $37.77 | $332K | Yes (planned) | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | Struthers Richard Scott, President & CEO | SSale | −13.2K | $37.11 | $490K | Yes (planned) | Form 4 ↗ |
| 2026-03-13 | 2026-03-12 | Vivaldi Coelho Rogerio Director | SSale | −523.00 | $36.77 | $19.2K | Yes (planned) | Form 4 ↗ |
| 2026-03-13 | 2026-03-12 | Vivaldi Coelho Rogerio, Director | SSale | −4.48K | $36.08 | $162K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Okey Stephanie Director | SSale | −3.00K | $39.67 | $119K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Schilke Tobin Chief Financial Officer | SSale | −6.71K | $39.67 | $266K | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also CRNX’s full analysis or the market-wide insider trading feed. The tabs above jump to CRNX’s other SEC data.
Source: SEC Form 4 filings for CRNX, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.